Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    influenza AND NIAID AND HIV AND AIDS AND HIV infections | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Perturbing of HIV Reservoir With Immune Stimulation
Conditions: AIDS;   HIV
Interventions: Biological: Fluarix;   Biological: Pneumovax;   Other: Placebo
2 Recruiting Acute Respiratory Infection Consortium
Condition: Influenza
Intervention:
3 Recruiting Screening Volunteers for Influenza Challenge Studies
Condition: Influenza, Human
Intervention:
4 Recruiting Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza
Conditions: Influenza A;   Influenza B
Interventions: Biological: Intravenous hyperimmune immunoglobulin (IVIG);   Biological: Placebo for IVIG
5 Recruiting Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali
Condition: Malaria
Interventions: Biological: Pfs25M-EPA/AS01;   Biological: Pfs230D1M-EPA/AS01;   Other: AS01;   Biological: Bexsero (Comparator Vaccine);   Biological: Fluarix;   Other: Normal Saline;   Drug: Coartem
6 Recruiting Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications
Condition: Influenza
Interventions: Drug: Amantadine, Ribavirin, Oseltamivir;   Drug: Oseltamivir
7 Recruiting Respiratory Virus Outpatient Study (FLU 002 Plus)
Condition: Influenza and Other Novel Respiratory Viruses
Intervention:
8 Recruiting Respiratory Virus Hospitalization Study (FLU 003 Plus)
Conditions: Influenza;   Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV);   Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
Intervention:

Study has passed its completion date and status has not been verified in more than two years.